https://www.acumenresearchandconsulting.com/
Home Services Industry Services Press Releases About Us Blogs Report Store Contact us

Transplant Diagnostics Market (By Product & Service: Reagents & Consumables, Instruments, Software & Services; By Technology: Molecular Assay, Non-molecular Assay; By Transplant Type: Solid Organ Transplantation, Stem Cell Transplantation, Soft Tissue Transplantation, Bone marrow Transplantation; By End User: Independent Reference Laboratories, Hospitals & Transplant Centers, Research Laboratories & Academic Institutes) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027

Published : Apr 2020

Report ID: ARC1846

Pages : 190

Format : Transplant Diagnostics Market (By Product & Service: Reagents & Consumables, Instruments, Software & Services; By Technology: Molecular Assay, Non-molecular Assay; By Transplant Type: Solid Organ Transplantation, Stem Cell Transplantation, Soft Tissue Transplantation, Bone marrow Transplantation; By End User: Independent Reference Laboratories, Hospitals & Transplant Centers, Research Laboratories & Academic Institutes) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027

Table Of Content:

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
   1.1.1. Definition of Transplant Diagnostics
   1.1.2. Market Segmentation
   1.1.3. List of Abbreviations
1.2. Summary
   1.2.1. Market Snapshot
   1.2.2. Transplant Diagnostics Market By Product & Service
     1.2.2.1. Global Transplant Diagnostics Market Revenue and Growth Rate Comparison By Product & Service (2016-2027)
     1.2.2.2. Global Transplant Diagnostics Market Revenue Share By Product & Service in 2019
     1.2.2.3. Reagents & Consumables
     1.2.2.4. Instruments
     1.2.2.5. Software & Services
   1.2.3. Transplant Diagnostics Market By Technology
     1.2.3.1. Global Transplant Diagnostics Market Revenue and Growth Rate Comparison By Technology (2016-2027)
     1.2.3.2. Molecular Assay
       1.2.3.2.1. PCR-based Molecular Assay
       1.2.3.2.2. Sequencing-based Molecular Assay
     1.2.3.3. Non-molecular Assay
       1.2.3.3.1. Serological Assay
       1.2.3.3.2. Mixed Lymphocyte Culture Assay
1.2.4. Transplant Diagnostics Market By Transplant Type
     1.2.4.1. Global Transplant Diagnostics Market Revenue and Growth Rate Comparison By Transplant Type (2016-2027)
     1.2.4.2. Solid Organ Transplantation
       1.2.4.2.1. Kidney Transplantation
       1.2.4.2.2. Liver Transplantation
       1.2.4.2.3. Heart Transplantation
       1.2.4.2.4. Lung Transplantation
       1.2.4.2.5. Pancreas Transplantation
       1.2.4.2.6. Other Organ Transplantations
     1.2.4.3. Stem Cell Transplantation
     1.2.4.4. Soft Tissue Transplantation
     1.2.4.5. Bone marrow Transplantation
   1.2.5. Transplant Diagnostics Market By End User
     1.2.5.1. Global Transplant Diagnostics Market Revenue and Growth Rate Comparison By End User (2016-2027)
     1.2.5.2. Independent Reference Laboratories
     1.2.5.3. Hospitals & Transplant Centers
     1.2.5.4. Research Laboratories & Academic Institutes
   1.2.6. Transplant Diagnostics Market By Geography
     1.2.6.1. Global Transplant Diagnostics Market Revenue and Growth Rate Comparison by Geography (2016-2027)
     1.2.6.2. North America Transplant Diagnostics Market Revenue and Growth Rate(2016-2027)
     1.2.6.3. Europe Transplant Diagnostics Market Revenue and Growth Rate(2016-2027)
     1.2.6.4. Asia-Pacific Transplant Diagnostics Market Revenue and Growth Rate(2016-2027)
     1.2.6.5. Latin America Transplant Diagnostics Market Revenue and Growth Rate(2016-2027)
     1.2.6.6. Middle East and Africa (MEA) Transplant Diagnostics Market Revenue and Growth Rate(2016-2027)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
   2.4.1. Bargaining Power of Suppliers
   2.4.2. Bargaining Power of Buyers
   2.4.3. Threat of Substitute
   2.4.4. Threat of New Entrants
   2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
   2.6.1. Raw Material and Suppliers
   2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2019
   2.8.1. Player Positioning Analysis
   2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Transplant Diagnostics Major Manufacturers in 2019
3.2. Manufacturing Plants Distribution of Global Transplant Diagnostics Major Manufacturers in 2019
3.3. R&D Status and Technology Source of Global Transplant Diagnostics Major Manufacturers in 2019
3.4. Raw Materials Sources Analysis of Global Transplant Diagnostics Major Manufacturers in 2019

CHAPTER 4. TRANSPLANT DIAGNOSTICS MARKET BY PRODUCT & SERVICE
4.1. Global Transplant Diagnostics Revenue By Product & Service
4.2. Reagents & Consumables
   4.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   4.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.3. Instruments
   4.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   4.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
4.4. Software & Services
   4.4.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   4.4.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)

CHAPTER 5. TRANSPLANT DIAGNOSTICS MARKET BY TECHNOLOGY
5.1. Global Transplant Diagnostics Revenue By Technology
5.2. Molecular Assay
   5.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   5.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
   5.2.3. PCR-based Molecular Assay
   5.2.4. Sequencing-based Molecular Assay
5.3. Non-molecular Assay
   5.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   5.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
   5.3.3. Serological Assay
   5.3.4. Mixed Lymphocyte Culture Assay

CHAPTER 6. TRANSPLANT DIAGNOSTICS MARKET BY TRANSPLANT TYPE
6.1. Global Transplant Diagnostics Revenue By Transplant Type
6.2. Solid Organ Transplantation
   6.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   6.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
   6.2.3. Kidney Transplantation
   6.2.4. Liver Transplantation
   6.2.5. Heart Transplantation
   6.2.6. Lung Transplantation
   6.2.7. Pancreas Transplantation
   6.2.8. Other Organ Transplantations
6.3. Stem Cell Transplantation
   6.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   6.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
6.4. Soft Tissue Transplantation
   6.4.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   6.4.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
6.5. Bone marrow Transplantation
   6.5.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   6.5.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)

CHAPTER 7. TRANSPLANT DIAGNOSTICS MARKET BY END USER
7.1. Global Transplant Diagnostics Revenue By End User
7.2. Independent Reference Laboratories
   7.2.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   7.2.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
7.3. Hospitals & Transplant Centers
   7.3.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   7.3.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)
7.4. Research Laboratories & Academic Institutes
   7.4.1. Market Revenue and Growth Rate, 2016 - 2027 ($Million)
   7.4.2. Market Revenue and Forecast, By Region, 2016 - 2027 ($Million)

CHAPTER 8. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET BY COUNTRY
8.1. North America Transplant Diagnostics Market Revenue and Growth Rate, 2016 - 2027 ($Million)
8.2. North America Transplant Diagnostics Market Revenue Share Comparison, 2016 & 2027 (%)
8.3. U.S.
   8.3.1. U.S. Transplant Diagnostics Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
   8.3.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
   8.3.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
   8.3.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
8.4. Canada
   8.4.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
   8.4.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
   8.4.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
   8.4.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)

CHAPTER 9. EUROPE TRANSPLANT DIAGNOSTICS MARKET BY COUNTRY
9.1. Europe Transplant Diagnostics Market Revenue and Growth Rate, 2016 - 2027 ($Million)
9.2. Europe Transplant Diagnostics Market Revenue Share Comparison, 2016 & 2027 (%)
9.3. UK
   9.3.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
   9.3.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
   9.3.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
   9.3.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
9.4. Germany
   9.4.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
   9.4.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
   9.4.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
   9.4.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
9.5. France
   9.5.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
   9.5.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
   9.5.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
   9.5.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
9.6. Spain
   9.6.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
   9.6.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
   9.6.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
   9.6.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
9.7. Rest of Europe
   9.7.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
   9.7.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
   9.7.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
   9.7.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)

CHAPTER 10. ASIA-PACIFIC TRANSPLANT DIAGNOSTICS MARKET BY COUNTRY
10.1. Asia-Pacific Transplant Diagnostics Market Revenue and Growth Rate, 2016 - 2027 ($Million)
10.2. Asia-Pacific Transplant Diagnostics Market Revenue Share Comparison, 2016 & 2027 (%)
10.3. China
   10.3.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
   10.3.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
   10.3.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
   10.3.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
10.4. Japan
   10.4.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
   10.4.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
   10.4.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
   10.4.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
10.5. India
   10.5.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
   10.5.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
   10.5.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
   10.5.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
10.6. Australia
   10.6.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
   10.6.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
   10.6.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
   10.6.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
10.7. South Korea
   10.7.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
   10.7.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
   10.7.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
   10.7.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
10.8. Rest of Asia-Pacific
   10.8.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
   10.8.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
   10.8.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
   10.8.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)

CHAPTER 11. LATIN AMERICA TRANSPLANT DIAGNOSTICS MARKET BY COUNTRY
11.1. Latin America Transplant Diagnostics Market Revenue and Growth Rate, 2016 - 2027 ($Million)
11.2. Latin America Transplant Diagnostics Market Revenue Share Comparison, 2016 & 2027 (%)
11.3. Brazil
   11.3.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
   11.3.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
   11.3.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
   11.3.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
11.4. Mexico
   11.4.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
   11.4.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
   11.4.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
   11.4.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
11.5. Rest of Latin America
   11.5.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)   
   11.5.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
   11.5.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
   11.5.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)

CHAPTER 12. MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET BY COUNTRY
12.1. Middle East & Africa Transplant Diagnostics Market Revenue and Growth Rate, 2016 - 2027 ($Million)
12.2. Middle East & Africa Transplant Diagnostics Market Revenue Share Comparison, 2016 & 2027 (%)
12.3. GCC
   12.3.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
   12.3.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
   12.3.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
   12.3.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
12.4. South Africa
   12.4.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
   12.4.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
   12.4.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
   12.4.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)
12.5. Rest of Middle East & Africa
   12.5.1. Market Revenue and Forecast By Product & Service, 2016 - 2027 ($Million)
   12.5.2. Market Revenue and Forecast By Technology, 2016 - 2027 ($Million)
   12.5.3. Market Revenue and Forecast By Transplant Type, 2016 - 2027 ($Million)
   12.5.4. Market Revenue and Forecast By End User, 2016 - 2027 ($Million)

CHAPTER 13. COMPANY PROFILE
13.1. BAG Healthcare
   13.1.1. Company Snapshot
   13.1.2. Overview
   13.1.3. Financial Overview
   13.1.4. Type Portfolio
   13.1.5. Key Developments
   13.1.6. Strategies
13.2. Becton
   13.2.1. Company Snapshot
   13.2.2. Overview
   13.2.3. Financial Overview
   13.2.4. Type Portfolio
   13.2.5. Key Developments
   13.2.6. Strategies
13.3. Biofortuna (UK)
   13.3.1. Company Snapshot
   13.3.2. Overview
   13.3.3. Financial Overview
   13.3.4. Type Portfolio
   13.3.5. Key Developments
   13.3.6. Strategies
13.4. bioMérieux S.A.
   13.4.1. Company Snapshot
   13.4.2. Overview
   13.4.3. Financial Overview
   13.4.4. Type Portfolio
   13.4.5. Key Developments
   13.4.6. Strategies
13.5. Bio-Rad Laboratories, Inc. (US)
   13.5.1. Company Snapshot
   13.5.2. Overview
   13.5.3. Financial Overview
   13.5.4. Type Portfolio
   13.5.5. Key Developments
   13.5.6. Strategies
13.6. CareDx (US)
   13.6.1. Company Snapshot
   13.6.2. Overview
   13.6.3. Financial Overview
   13.6.4. Type Portfolio
   13.6.5. Key Developments
   13.6.6. Strategies
13.7. Dickinson and Company (US)
   13.7.1. Company Snapshot
   13.7.2. Overview
   13.7.3. Financial Overview
   13.7.4. Type Portfolio
   13.7.5. Key Developments
   13.7.6. Strategies
13.8. F. Hoffman-La Roche Ltd. (Switzerland)
   13.8.1. Company Snapshot
   13.8.2. Overview
   13.8.3. Financial Overview
   13.8.4. Type Portfolio
   13.8.5. Key Developments
   13.8.6. Strategies
13.9. GenDx (Netherlands)
   13.9.1. Company Snapshot
   13.9.2. Overview
   13.9.3. Financial Overview
   13.9.4. Type Portfolio
   13.9.5. Key Developments
   13.9.6. Strategies
13.10. Others
   13.10.1. Company Snapshot
   13.10.2. Overview
   13.10.3. Financial Overview
   13.10.4. Type Portfolio
   13.10.5. Key Developments
   13.10.6. Strategies

CHAPTER 14. RESEARCH APPROACH
14.1. Research Methodology
   14.1.1. Initial Data Search
   14.1.2. Secondary Research
   14.1.3. Primary Research
14.2. Assumptions and Scope

Frequently Asked Questions

What is transplant diagnostics?

Transplant diagnostics is an integral procedure in organ transplantation. This is performed to check the compatibility between donor and the recipient and it plays a crucial role at every stage of organ transplantation.

How much is the transplant diagnostics market size?

The global transplant diagnostics market size is expected to reach around US$ 5,902.2 Mn by 2027.

How much is the CAGR of transplant diagnostics market?

The global transplant diagnostics market is expected to grow at a CAGR of 7.4% from 2020 to 2027.

Which factors driving the transplant diagnostics market value?

The increasing number of transplant procedures along with the increasing awareness leads to increased number of organ donors is primarily driving the market value.

Which product segment accounted for the major share in the transplant diagnostics market?

Reagents & Consumables accounted for the major share in the market.

Which region is leading the market share?

North America is leading the market with a major share in terms of value.

Which are the key players of transplant diagnostics market?

The players profiled in the report include BAG Healthcare, Becton, Biofortuna (UK), bioMérieux S.A., Bio-Rad Laboratories, Inc. (US), CareDx (US), Dickinson and Company (US), F. Hoffman-La Roche Ltd. (Switzerland), GenDx (Netherlands), Hologic (US), Illumina, Inc. (US), Immucor, Inc. (US), Luminex Corporation (US), QIAGEN N.V. (Netherlands), Takara Bio, and Thermo Fisher Scientific Inc. (US).

Select Licence Type

Single User

US$ 4500

Multi User

US$ 7000

Excel Datapack

US$ 2000

Why Acumen Research And Consulting

100%

Customer Satisfaction

24x7

Availability - we are always there when you need us

200+

Fortune 50 Companies trust Acumen Research and Consulting

80%

of our reports are exclusive and first in the industry

100%

more data and analysis

1000+

reports published till date